Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -141,405 | -19,816 | -98,776 | -67,475 | -54,121 |
| Depreciation Amortization | 205 | 1,029 | 799 | 337 | 270 |
| Other Working Capital | 2,169 | -6,092 | 28,699 | -2,042 | -590 |
| Other Operating Activity | 21,030 | -88,007 | 13,801 | 8,268 | 5,808 |
| Operating Cash Flow | $-118,001 | $-112,886 | $-55,477 | $-60,912 | $-48,633 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -28,495 | N/A | 1,474 | -738 | 4,269 |
| PPE Investments | -110 | -1,603 | -1,096 | N/A | -388 |
| Net Acquisitions | N/A | 107,375 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | -1,793 | 0 | 0 |
| Investing Cash Flow | $-28,605 | $105,772 | $-1,415 | $-738 | $3,881 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 28,588 | 40,259 | N/A | N/A |
| Debt Issued | N/A | 29,921 | N/A | N/A | N/A |
| Common Stock Issued | 26,627 | 66,271 | 1,199 | 109,216 | 67,968 |
| Other Financing Activity | 0 | -42 | -148 | 0 | 0 |
| Financing Cash Flow | $26,627 | $124,738 | $41,310 | $109,216 | $67,968 |
| Beginning Cash Position | 240,551 | 122,927 | 138,509 | 90,943 | 67,727 |
| End Cash Position | 120,572 | 240,551 | 122,927 | 138,509 | 90,943 |
| Net Cash Flow | $-119,979 | $117,624 | $-15,582 | $47,566 | $23,216 |
| Free Cash Flow | |||||
| Operating Cash Flow | -118,001 | -112,886 | -55,477 | -60,912 | -48,633 |
| Capital Expenditure | -119 | -1,774 | -1,096 | N/A | -388 |
| Free Cash Flow | -118,120 | -114,660 | -56,573 | -60,912 | -49,021 |